Rainbow Rare Earths Phalaborwa project shaping up to be one of the lowest cost producers globally. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksEHP.L Share News (EHP)

  • There is currently no data for EHP

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Neptune Calculus Reports Increase In Portfolio Value In Half Year

Thu, 13th Aug 2015 16:21

LONDON (Alliance News) - Neptune Calculus Income and Growth VCT said Thursday its portfolio saw an increase in value in the first half of 2015, and it saw a return per share of 2 pence.

The company invests around 75% of its funds in unquoted or AIM-quoted investments across a range of sectors.

The venture capital trust proposed an interim dividend of 1.5 pence.

It had a net asset value of 46.6 pence as at end-June, but said that net asset value had declined to 45.4 pence as at end-July.

It said that during the period the overall value of its unquoted portfolio increased by 10% due to an increase in the value of Terrain Energy Ltd. Whilst its quoted portfolio value fell by around 2.4%, compared with an increase of 7.6% in the AIM market, mostly due to the fall in the share price of Epistem Holdings PLC.

"There are signs of a strengthening economy, and we believe the investments in the portfolio are well placed to benefit from improving conditions," the trust said in a statement.

Shares in the trust were untraded Thursday. They last closed at 37.00 pence.

By Hana Stewart-Smith; hanassmith@alliancenews.com; @HanaSSAllNews

Copyright 2015 Alliance News Limited. All Rights Reserved.

More News
28 Oct 2014 08:27

Epistem Files For Import, Sales Licence For Genedrive In India

Read more
22 Jul 2014 09:23

Epistem Expects Full Year Loss, Signs Funding Agreement For Genedrive

Read more
7 Apr 2014 16:00

DIRECTOR DEALINGS: Epistem Holdings Managing Director Transfers Shares

LONDON (Alliance News) - Epistem Holdings PLC Monday said Managing Director Catherine Booth transferred 4,877 shares to her self invested personal pension fund at a price of 328 pence. Booth's interest remains unchanged at 985,642 shares following this transaction, representing a 10.11% sta

Read more
25 Mar 2014 13:12

Epistem Loss Widens As It Ups Investment, Revenue Declines

LONDON (Alliance News) - Epistem Holdings PLC Tuesday posted a widened pretax loss as it saw revenue decline in the half-year ended December 31, 2013, and it upped its investment in the development of its Genedrive product. Genedrive is a molecular diagnostic technology. Epistem poste

Read more
25 Mar 2014 06:12

UK Earnings, Trading Statements Calendar - Week Ahead

Tuesday, March 25 
888 Holdi

Read more
24 Mar 2014 15:39

UK Earnings, Trading Statements Calendar - Week Ahead

Tuesday, March 25 
888 Holdi

Read more
27 Jan 2014 10:15

EpiStem Appoints COO And Technical Director For Diagnostics Division

LONDON (Alliance News) - EpiStem Holdings PLC said Monday that it had appointed for its Diagnostics division Allan Brown as chief operating office and Peter Foster as technical director. Brown will take on the role February 1. He previously held positions at Tepnel Life Sciences PLC and QIA

Read more
3 Dec 2013 15:59

Hangar 8 CEO makes first sale to meet demand for stock

Hangar 8, a privately-owned passenger jet aircraft owner, announced that Dustin Dryden, its Chief Executive Office, made his first ever sale of company stock with the disposal of 750,000 shares to meet institutional demand. Dryden sold the shares at 205p each for a total of £1.54m and reduced his

Read more
19 Nov 2013 15:56

Neptune Calculus Income & Growth VCT Hit By Epistem Share Decline

Read more
22 Oct 2013 11:41

UPDATE: Epistem Widens Pretax Losses Following Delays Of Key Product, Looking To Launch In 2014

Read more
22 Oct 2013 08:05

Epistem Widens Pretax Losses Following Delays Of Key Product

Read more
7 Oct 2013 10:12

DIRECTOR DEALINGS: Epistem Chief Executive, Directors Acquire Shares

Read more
9 Sep 2013 11:37

UK Winners & Losers: BG Down 5%, CSR Up 5%; Mediazest Drops 21%

Read more
9 Sep 2013 11:34

Epistem Holdings Says Expansion Talks With US Becton Dickinson Failed

Read more
9 Sep 2013 08:00

EpiStem loses distribution contract for TB test

AIM-listed biotech firm EpiStem has maintained its full-year guidance for the period just gone but admitted that talks over a key supply and distribution agreement for its TB test have fallen through. The company was in discussions with medical technology company Becton Dickinson (BD) to expand the

Read more

Quickpicks are a member only feature

Login to your account